1. Essential medicines for breast cancer in low and middle income countries. Issue 1 (December 2015) Authors: Bazargani, Y.; de Boer, A.; Schellens, J.; Leufkens, H.; Mantel-Teeuwisse, Aukje Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intensive monitoring of adverse drug events associated with the use of new glucose‐lowering drugs: results from an inception cohort study in Portugal. Issue 4 (17th December 2019) Authors: Torre, C.; Guerreiro, J.; Longo, P.; Raposo, J. F.; Leufkens, H.; Martins, A. P. Journal: Diabetic medicine Issue: Volume 37:Issue 4(2020) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort. Issue 4 (April 2016) Authors: Bours, S.; Vries, F.; Bergh, J.; Lalmohamed, A.; Staa, T.; Leufkens, H.; Geusens, P.; Drent, M.; Harvey, N. Journal: Osteoporosis international Issue: Volume 27:Issue 4(2016) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗